About GondolaBio
GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. A sister company of BridgeBio, GondolaBio secured $300M in private financing from external investors in August 2024. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas in monogenic rare diseases. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation.
Who You Are
The Associate Director/Director/Sr. Director, BD & Ops role will be a critically important player who owns & shapes scientific, operational, and external-facing facets of value-driving subsidiaries. This includes developing and owning the business plan, scientific plan, strategy, budget, and more. Success in this role requires a keen understanding of molecular biology, chemistry, translational medicine, clinical development, and a willingness to interpret & question scientific strategy. You will help boil down complex issues into bite-size, easy-to-understand information regarding the programs you cover from a scientific and business/financial perspective. The role will include responsibilities for competitive intelligence, NPV modeling, leading teams, and managing industry relationships. You will be relied upon to be a detailed and rational problem-solver who thinks independently, improvises, and inspires excellence.
Job details are sourced from the employer's original posting.
Open job postingAbout the company
This company is involved in clinical pharmacology and early clinical development, focusing on early clinical sciences and development strategy from first-in-human through Phase 2. They also lead quantitative sciences including data analytics, pharmacometrics, biostatistics, and data management to inform dose selection and program development.